In vitro activity of linezolid against Gram-positive uropathogens of hospitalized patients with complicated urinary tract infections

Onda, H. and Wagenlehner, F. M. E. and Lehn, Norbert and Naber, K. G. (2001) In vitro activity of linezolid against Gram-positive uropathogens of hospitalized patients with complicated urinary tract infections. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 18 (3). pp. 263-266. ISSN 0924-8579

Full text not available from this repository. (Request a copy)

Abstract

The antimicrobial activity of linezolid, a recently developed antibiotic agent active against Gram-positive bacteria, was tested against pathogens from three different collections. (1) Uropathogens from hospitalized urological patients (1990/1991) with complicated and/or hospital-acquired UTls, Urologic Clinic, Hospital St. Elisabeth, Straubing. (2) Uropathogens from a multi-centre study (1995/1996) comprising 37 urological centres throughout Germany. (3) MRSA isolates of patients and staff (1999/2000) within the Hospital St. Elisabeth, Straubing. Genotyping of the latter isolates was performed by pulsed-field-electrophoresis. The minimal inhibitory concentrations (MIC) of linezolid determined by an agar (Isosensitest) dilution method using a multipoint inoculator and an inoculum of 10(4) cfu per point ranged for methicillin susceptible Staphylococcus aureus (MSSA) (n = 27) between 2 and 4 mg/l, for methicillin resistant S. aureus (MRSA) (n = 35) between I and 2 mg/l, for methicillin susceptible coagulase-negative staphylococci (CNS) (MSSE) (n = 67) between 0.5 and 4 mg/l, for methicillin resistant CNS (MRSE) (n = 19) between 0.25 and 2 mg/l, for Enterococcus. faecalis (n = 184) between 0.5 and 4 mg/l, for E. faecium (it = 3) 2 mg/l and for Streptococcus spp. (n = 4) between 0.25 and I mg/l, indicating that all strains were susceptible. According to the in vitro activity, linezolid may be considered a promising antibacterial agent for the treatment of complicated UTI caused by Gram-positive uropathogens. Thus, linezolid should be evaluated in a clinical study. (C) 2001 Elsevier Science BN. and International Society of Chemotherapy. All rights reserved.

Item Type: Article
Uncontrolled Keywords: ; linezolid; oxazolidinone; urinary tract infections (UTI); gram-positive; uropathogens
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Depositing User: Dr. Gernot Deinzer
Date Deposited: 01 Mar 2022 07:39
Last Modified: 01 Mar 2022 07:39
URI: https://pred.uni-regensburg.de/id/eprint/41882

Actions (login required)

View Item View Item